Schwenksville, PA, United States of America

Robert L LaFemina

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 2008-2013

Loading Chart...
5 patents (USPTO):

Title: Spotlight on Inventor Robert L. LaFemina

Introduction

Robert L. LaFemina, based in Schwenksville, PA, is a notable inventor recognized for his significant contributions to the field of biotechnology and pharmaceutical development. With a total of five patents to his name, LaFemina has focused much of his work on RNA-dependent RNA viral polymerases, particularly in relation to hepatitis C virus (HCV) treatment.

Latest Patents

LaFemina's latest patents include innovative nucleoside derivatives designed as inhibitors of RNA-dependent RNA viral polymerase. This groundbreaking invention offers nucleoside compounds that play a crucial role in inhibiting RNA-dependent RNA viral replication, providing therapeutic options for individuals suffering from HCV infections. His research also includes the development of pharmaceutical compositions that incorporate these nucleoside compounds, either alone or combined with other agents that target RNA-dependent RNA viral infections.

Another significant patent involves advancing methods for producing replicons containing a functional genotype 2b NS5B sequence. This work is instrumental in enhancing the efficacy of HCV treatments by providing a reliable model for testing compounds aimed at interrupting HCV replication processes.

Career Highlights

Throughout his career, Robert L. LaFemina has been affiliated with reputable companies in the biotechnology sector, including Merck & Company and Isis Pharmaceuticals. His work within these organizations has allowed him to push the boundaries of scientific innovation effectively, particularly in the development of antiviral therapies.

Collaborations

LaFemina’s career has also been marked by fruitful collaborations with esteemed colleagues such as Amy L. Simcoe and Donald J. Graham. Their combined expertise has undoubtedly contributed to the success of the projects they undertook together.

Conclusion

Robert L. LaFemina's contributions to the field of RNA viral research and antiviral drug development have positioned him as a formidable inventor in biomedical innovation. His continued efforts in designing effective treatments for HCV highlight the impact that dedicated inventors can have on public health and the advancement of science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…